Valley County Health System

valleycountyhealthsystem.org

Based in Ord, Nebraska, Valley County Health System (VCHS) is a growing not-for-profit, county-owned health system that includes a 16-bed Critical Access Hospital, three medical clinics, a specialty clinic, and home health and hospice care. We're dedicated to providing an extensive range of healthcare services to central Nebraskans, specifically to those residing in Valley County and neighboring counties, with compassionate care delivered by people our patients know and trust. We provide advanced technology and services in a modern yet comfortable atmosphere, while supporting continued growth for our communities.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

PREMIER INC. SUPPORTS FDA, DEA REFORMS AND REGULATORY WAIVERS TO COUNTER DRUG SHORTAGES

Premier Inc. | July 24, 2020

news image

Premier Inc. today provided the U.S. Food and Drug Administration (FDA) and the U.S. Drug Enforcement Administration (DEA) with a list of reforms and regulatory waivers that the company believes should be extended beyond the COVID-19 pandemic and made permanent thereafter in order to prevent drug shortages. “During the height of the COVID-19 pandemic, we saw demand for many common pharmaceuticals surge by an average of more than 150 percent,” said Blair Childs, Premier...

Read More

Pharmacy Market

CATALYST CLINICAL RESEARCH ANNOUNCES THE ACQUISITION OF GENPRO RESEARCH

PRNewswire | July 21, 2023

news image

Catalyst Clinical Research an industry-leading provider of specialized clinical development solutions, announced today it has acquired Genpro Research ("Genpro"), a Massachusetts-based global clinical research organization with staff in the US, India, and Ireland. Genpro is a next generation services and technology partner for the pharmaceutical, biotechnology, and medical devices industry with expertise in biometrics, medical writing, RWE, and AI enabled automation pr...

Read More

Pharmacy Market

HARBOUR BIOMED ANNOUNCES IND APPROVAL FOR NEXT-GEN ANTI-TSLP FULLY HUMAN MONOCLONAL ANTIBODY

Harbour BioMed | February 22, 2022

news image

Harbour BioMed announced that China National Medical Products Administration had approved its investigational new drug (IND) application for HBM9378 a next-gen fully human antibody targeting thymic stromal lymphopoietin for the treatment of moderate-to-severe asthma. HBM9378/SKB378 is a co-development project conducted by HBM and Kelun-Biotech, who together equally share the global rights in respect of HBM9378. The IND approval of HBM9378 is an achievement of the strategic collabo...

Read More

Pharmacy Market

SENSYNE HEALTH AND PHESI FORM A JOINT COMMERCIAL DEVELOPMENT PARTNERSHIP WITH A LEADING PHARMACEUTICAL COMPANY

Sensyne Health, Phesi | May 24, 2021

news image

Sensyne Health plc, the Clinical AI company, today announced that it has entered a joint commercial clinical development partnership in an undisclosed disease area with a major pharmaceutical company that is an existing client of Phesi with its U.S.-based strategic partner Phesi Inc. Sensyne and Phesi have entered into a joint commercial collaboration with a pharmaceutical customer for the first time since forming a strategic alliance in January 2021. The development work will con...

Read More
news image

PREMIER INC. SUPPORTS FDA, DEA REFORMS AND REGULATORY WAIVERS TO COUNTER DRUG SHORTAGES

Premier Inc. | July 24, 2020

Premier Inc. today provided the U.S. Food and Drug Administration (FDA) and the U.S. Drug Enforcement Administration (DEA) with a list of reforms and regulatory waivers that the company believes should be extended beyond the COVID-19 pandemic and made permanent thereafter in order to prevent drug shortages. “During the height of the COVID-19 pandemic, we saw demand for many common pharmaceuticals surge by an average of more than 150 percent,” said Blair Childs, Premier...

Read More
news image

Pharmacy Market

CATALYST CLINICAL RESEARCH ANNOUNCES THE ACQUISITION OF GENPRO RESEARCH

PRNewswire | July 21, 2023

Catalyst Clinical Research an industry-leading provider of specialized clinical development solutions, announced today it has acquired Genpro Research ("Genpro"), a Massachusetts-based global clinical research organization with staff in the US, India, and Ireland. Genpro is a next generation services and technology partner for the pharmaceutical, biotechnology, and medical devices industry with expertise in biometrics, medical writing, RWE, and AI enabled automation pr...

Read More
news image

Pharmacy Market

HARBOUR BIOMED ANNOUNCES IND APPROVAL FOR NEXT-GEN ANTI-TSLP FULLY HUMAN MONOCLONAL ANTIBODY

Harbour BioMed | February 22, 2022

Harbour BioMed announced that China National Medical Products Administration had approved its investigational new drug (IND) application for HBM9378 a next-gen fully human antibody targeting thymic stromal lymphopoietin for the treatment of moderate-to-severe asthma. HBM9378/SKB378 is a co-development project conducted by HBM and Kelun-Biotech, who together equally share the global rights in respect of HBM9378. The IND approval of HBM9378 is an achievement of the strategic collabo...

Read More
news image

Pharmacy Market

SENSYNE HEALTH AND PHESI FORM A JOINT COMMERCIAL DEVELOPMENT PARTNERSHIP WITH A LEADING PHARMACEUTICAL COMPANY

Sensyne Health, Phesi | May 24, 2021

Sensyne Health plc, the Clinical AI company, today announced that it has entered a joint commercial clinical development partnership in an undisclosed disease area with a major pharmaceutical company that is an existing client of Phesi with its U.S.-based strategic partner Phesi Inc. Sensyne and Phesi have entered into a joint commercial collaboration with a pharmaceutical customer for the first time since forming a strategic alliance in January 2021. The development work will con...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us